Literature DB >> 18088878

Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.

Ahmad N Chaudhry1, Salvatore L Ruggiero.   

Abstract

Bisphosphonates are a class of compounds approved for the treatment of multiple myeloma, hypercalcemia of malignancy, osteolytic lesions of metastatic disease, Paget's disease, and most commonly, osteoporosis. Recently, these drugs have been associated with a new clinical entity, bisphosphonate related osteonecrosis (BRON) which is characterized by jaw necrosis that typically presents following dentoalveolar surgery. The pathogenesis for this complication appears to related to bisphosphonate mediated inhibition of osteoclast function and normal bone remodeling. This complication can have a significant impact on the quality of life for those patients with advanced stages of necrosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18088878     DOI： 10.1016/j.coms.2007.01.005

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN： 1042-3699            Impact factor:   2.802


  8 in total

1.  Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospital.

Authors:  Zaid H Baqain; Faleh A Sawair; Zaid Tamimi; Nazzal Bsoul; Ghazi Al Edwan; Jamal K Almasad; Abdalla A Abbadi
Journal:  Ann R Coll Surg Engl       Date:  2010-06-01       Impact factor: 1.891

2.  Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.

Authors:  S Zafar; D E Coates; M P Cullinan; B K Drummond; T Milne; G J Seymour
Journal:  Clin Oral Investig       Date:  2016-01-22       Impact factor: 3.573

3.  In vitro and in vivo studies using non-traditional bisphosphonates.

Authors:  Lilian I Plotkin; Sonja Buvinic; Julián Balanta-Melo
Journal:  Bone       Date:  2020-02-26       Impact factor: 4.398

4.  Managing bisphosphonate-related osteonecrosis of the jaws with xenografts: a case report.

Authors:  Aluísio Martins de Oliveira Ruellas; Daiane Cristina Peruzzo; Marcelo Henrique Napimoga
Journal:  Clin Case Rep       Date:  2017-07-14

5.  The Influence of Local Pamidronate Application on Alveolar Dimensional Preservation after Tooth Extraction-An Animal Experimental Study.

Authors:  Frederic Kauffmann; Christian Höhne; Alexandre Thomas Assaf; Tobias Vollkommer; Jan Semmusch; Aline Reitmeier; Jamal Michel Stein; Max Heiland; Ralf Smeets; Rico Rutkowski
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

6.  Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.

Authors:  Yukie Tanaka; Kyaw Thu Aung; Mitsuaki Ono; Akihiro Mikai; Anh Tuan Dang; Emilio Satoshi Hara; Ikue Tosa; Kei Ishibashi; Aya Ono-Kimura; Kumiko Nawachi; Takuo Kuboki; Toshitaka Oohashi
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

7.  Bone repair in craniofacial defects treated with different doses of alendronate: a histological, histomorphometric, and immunohistochemical study.

Authors:  Naylin de Oliveira; Jefferson Oliveira; Letícia de Souza Moraes; Suyany Gabriely Weiss; Luís Henrique Chaves; Thais Costa Casagrande; Tatiana Miranda Deliberador; Allan Fernando Giovanini; João César Zielak; Rafaela Scariot
Journal:  Clin Oral Investig       Date:  2018-10-09       Impact factor: 3.573

Review 8.  The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention.

Authors:  Olga Di Fede; Vera Panzarella; Rodolfo Mauceri; Vittorio Fusco; Alberto Bedogni; Lorenzo Lo Muzio; Giuseppina Campisi
Journal:  Biomed Res Int       Date:  2018-09-16       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.